Detalhe da pesquisa
1.
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
Lancet
; 403(10443): 2534-2550, 2024 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797178
2.
Global, regional, and national estimates of the impact of a maternal Klebsiella pneumoniae vaccine: A Bayesian modeling analysis.
PLoS Med
; 20(5): e1004239, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216371
3.
New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants.
BMC Med
; 21(1): 177, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183242
4.
Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies.
Clin Infect Dis
; 73(Suppl_3): S177-S179, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472571
5.
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.
Clin Infect Dis
; 73(4): e1011-e1017, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493317
6.
Outbreaks of unexplained neurologic illness - Muzaffarpur, India, 2013-2014.
MMWR Morb Mortal Wkly Rep
; 64(3): 49-53, 2015 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25632950
7.
The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens.
Vaccine
; 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38876836
8.
Vaccine value profile for Klebsiella pneumoniae.
Vaccine
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503661
9.
The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness.
Lancet Infect Dis
; 2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000374
10.
Genomics for antimicrobial resistance surveillance to support infection prevention and control in health-care facilities.
Lancet Microbe
; 4(12): e1040-e1046, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977161
11.
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022.
Vaccine
; 41(48): 7047-7059, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777450
12.
Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
Vaccine
; 41 Suppl 2: S7-S40, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422378
13.
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.
Lancet Infect Dis
; 23(1): e2-e21, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35952703
14.
Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group.
Lancet Microbe
; 4(12): e1035-e1039, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977164
15.
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.
Clin Infect Dis
; 54 Suppl 4: S348-54, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22544202
16.
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Vaccine
; 40(26): 3506-3510, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184927
17.
An algorithmic approach to identifying the aetiology of acute encephalitis syndrome in India: results of a 4-year enhanced surveillance study.
Lancet Glob Health
; 10(5): e685-e693, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427525
18.
Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study.
Lancet Glob Health
; 10(9): e1317-e1325, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961355
19.
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
Vaccine
; 39(30): 4013-4024, 2021 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119350
20.
Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count.
Clin Infect Dis
; 51(3): 359-62, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20569064